2,5-Bis(2,2,2-trifluoroethoxy)-N-(2-{[3-(trifluoromethyl)phenyl]formamido}ethyl)benzamide

Catalog No. :
ACPCNB840
CAS No. :
338404-44-7
Molecular Formula :
C21H17F9N2O4
Molecular Weight :
532.36

IUPAC Name:2,5-bis(2,2,2-trifluoroethoxy)-N-(2-(3-(trifluoromethyl)benzamido)ethyl)benzamide

2,5-Bis(2,2,2-trifluoroethoxy)-N-(2-{[3-(trifluoromethyl)phenyl]formamido}ethyl)benzamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$285.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2,5-Bis(2,2,2-trifluoroethoxy)-N-(2-{[3-(trifluoromethyl)phenyl]formamido}ethyl)benzamide
IUPAC Name2,5-bis(2,2,2-trifluoroethoxy)-N-(2-(3-(trifluoromethyl)benzamido)ethyl)benzamide
MDL No.MFCD00139600
Molecular FormulaC21H17F9N2O4
Molecular Weight532.36
SMILESO=C(NCCNC(C1=CC=CC(C(F)(F)F)=C1)=O)C2=CC(OCC(F)(F)F)=CC=C2OCC(F)(F)F
InChI KeyKIOHZFSCNPVHBN-UHFFFAOYSA-N
Synonym2,5-bis(2,2,2-trifluoroethoxy)-N-(2-{[3-(trifluoromethyl)phenyl]formamido}ethyl)benzamide;2,5-BIS(2,2,2-TRIFLUOROETHOXY)-N-(2-([3-(TRIFLUOROMETHYL)BENZOYL]AMINO)ETHYL)BENZENECARBOXAMIDE;Benzamide, 2,5-bis(2,2,2-trifluoroethoxy)-N-[2-[[3-(trifluoromethyl)benzoyl]amino]ethyl]-
CAS No.338404-44-7

Synthetic Route by SureRoute

1. ACPCNB840 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACJCEU863 route compound structure diagram
    ACJCEU86335480-52-5 In Stock
  4. Then
  5. ACPCNB840 route product structure diagram
    ACPCNB840338404-44-7
Inquiry

2. ACPCNB840 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACHTIW589 route compound structure diagram
    ACHTIW589454-92-2 In Stock
  4. Then
  5. ACPCNB840 route product structure diagram
    ACPCNB840338404-44-7
Inquiry

Comments (0)